Qinghai Meng

机构：Nanjing University of Chinese Medicine · ORCID：0000-0001-8039-4713

发表论文 94 篇 · 总被引 2596 次 · h-index 29

代表论文

• Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer (2022 · Pharmacology & Therapeutics · 被引 147)
• Novel insights: Dynamic foam cells derived from the macrophage in atherosclerosis (2021 · Journal of Cellular Physiology · 被引 57)
• Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis (2022 · Phytomedicine · 被引 54)
• Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide (2023 · Microbiome · 被引 51)
• Catalpol Inhibits Macrophage Polarization and Prevents Postmenopausal Atherosclerosis Through Regulating Estrogen Receptor Alpha (2021 · Frontiers in Pharmacology · 被引 29)
• Potential targets for the treatment of MI: GRP75-mediated Ca2+ transfer in MAM (2024 · European Journal of Pharmacology · 被引 26)